Proton pump inhibitors: Review of reported risks and controversies
Sign Up to like & getrecommendations! Published in 2018 at "Laryngoscope Investigative Otolaryngology"
DOI: 10.1002/lio2.187
Abstract: Proton pump inhibitors (PPIs) are among the most prescribed classes of drugs in this day and age. These may be beneficial to treat many gastrointestinal conditions, such as gastroesophageal reflux or Barrett's esophagus as well… read more here.
Keywords: pump inhibitors; reported risks; review reported; inhibitors review ... See more keywords
PI3K inhibitors: review and new strategies
Sign Up to like & getrecommendations! Published in 2020 at "Chemical Science"
DOI: 10.1039/d0sc01676d
Abstract: The search is on for effective specific inhibitors for PI3Kα mutants. read more here.
Keywords: new strategies; review new; pi3k inhibitors; inhibitors review ... See more keywords
Caspase inhibitors: a review of recently patented compounds (2013-2015)
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2017.1378426
Abstract: ABSTRACT Introduction: Although many caspase inhibitors have been patented, caspase inhibitors have not entered the market due to their toxicity and poor pharmacokinetic profile. Areas covered: In this article, we review patents (2013–2015) for peptide… read more here.
Keywords: 2013 2015; caspase inhibitor; caspase; review recently ... See more keywords
PDE1 inhibitors: a review of the recent patent literature (2008-present)
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2022.2027910
Abstract: ABSTRACT Introduction PDE1 has been demonstrated to be a potential drug target for a variety of diseases, such as Alzheimer’s disease and cardiovascular disease. In the past decades, numerous PDE1 inhibitors with structural diversities have… read more here.
Keywords: pde1 inhibitors; pde1; inhibitors review; 2008 present ... See more keywords